6.15
price up icon1.49%   0.09
after-market Dopo l'orario di chiusura: 6.12 -0.03 -0.49%
loading
Precedente Chiudi:
$6.06
Aprire:
$6
Volume 24 ore:
549.98K
Relative Volume:
0.71
Capitalizzazione di mercato:
$437.42M
Reddito:
$11.40B
Utile/perdita netta:
$-95.73M
Rapporto P/E:
-3.0905
EPS:
-1.99
Flusso di cassa netto:
$-64.37M
1 W Prestazione:
-4.65%
1M Prestazione:
+10.41%
6M Prestazione:
-38.50%
1 anno Prestazione:
+99.03%
Intervallo 1D:
Value
$5.95
$6.16
Intervallo di 1 settimana:
Value
$5.87
$6.625
Portata 52W:
Value
$2.41
$12.22

Mind Medicine Inc Stock (MNMD) Company Profile

Name
Nome
Mind Medicine Inc
Name
Telefono
212-220-6633
Name
Indirizzo
ONE WORLD TRADE CENTER, NEW YORK
Name
Dipendente
57
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
MNMD's Discussions on Twitter

Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-12-09 Ripresa ROTH Capital Buy
2022-11-16 Iniziato RBC Capital Mkts Outperform
2022-08-26 Iniziato Oppenheimer Outperform
2022-08-10 Iniziato Cantor Fitzgerald Overweight
2022-05-04 Iniziato ROTH Capital Buy
2021-06-28 Iniziato Maxim Group Buy
Mostra tutto

Mind Medicine Inc Borsa (MNMD) Ultime notizie

pulisher
Nov 04, 2024

Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate (NASDAQ:MNMD) - Seeking Alpha

Nov 04, 2024
pulisher
Oct 31, 2024

Mind Medicine (MindMed) (MNMD) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 27, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Oct 27, 2024
pulisher
Oct 24, 2024

MNMDMind Medicine (MindMed) Inc. Common Shares Latest Stock News & Market Updates - StockTitan

Oct 24, 2024
pulisher
Oct 24, 2024

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update - The Globe and Mail

Oct 24, 2024
pulisher
Oct 19, 2024

FDA is said to see “path forward” for ecstasy-based drug (DRUG:NASDAQ) - Seeking Alpha

Oct 19, 2024
pulisher
Oct 17, 2024

MindMed announces exchange agreement with investors By Investing.com - Investing.com

Oct 17, 2024
pulisher
Oct 16, 2024

Bright Minds rally ends as psychedelic stocks extend volatility - MSN

Oct 16, 2024
pulisher
Oct 16, 2024

Bright Minds stock cools amid psychedelic volatility (DRUG:NASDAQ) - Seeking Alpha

Oct 16, 2024
pulisher
Oct 15, 2024

(MNMD) Investment Analysis and Advice - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Rating Upgraded by Leerink Partnrs - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated at Leerink Partners - MarketBeat

Oct 14, 2024
pulisher
Oct 12, 2024

Mind Medicine assumed with an Outperform at Leerink - Yahoo Finance

Oct 12, 2024
pulisher
Oct 05, 2024

Trend Tracker for (MNMD) - Stock Traders Daily

Oct 05, 2024
pulisher
Oct 02, 2024

"TNT Radio" Jeff Ghaemaghamy on Mind Medicine with Charles Kovess28 January 2024 (Podcast Episode 2024)News - imdb

Oct 02, 2024
pulisher
Oct 02, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

MindMed's SWOT analysis: psychedelic stock's potential in anxiety treatment - Investing.com

Oct 01, 2024
pulisher
Sep 28, 2024

Marshall Wace LLP Has $15.58 Million Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat

Sep 28, 2024
pulisher
Sep 26, 2024

Mind Medicine's chief medical officer sells shares worth over $41,000 By Investing.com - Investing.com UK

Sep 26, 2024
pulisher
Sep 25, 2024

MindMed executive sells over $26k in company stock By Investing.com - Investing.com South Africa

Sep 25, 2024
pulisher
Sep 25, 2024

Mind Medicine's chief medical officer sells shares worth over $41,000 - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Generalized Anxiety Disorder Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, MOA, ROA by DelveInsight | Pfizer Inc., GlaxoSmithKline, Eli Lilly and Company, MindMed, VistaGen Pharma - Barchart

Sep 25, 2024
pulisher
Sep 25, 2024

Rhumbline Advisers Makes New $679,000 Investment in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

Generalized Anxiety Disorder Global Market is Booming Across - openPR

Sep 24, 2024
pulisher
Sep 24, 2024

(MNMD) Proactive Strategies - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 20, 2024

Mankind Pharma: Rs 10000 crore fund raise via this routeDetails - ET Now

Sep 20, 2024
pulisher
Sep 20, 2024

Mankind Pharma to raise up to ₹10,000 crore through NCDs - CNBCTV18

Sep 20, 2024
pulisher
Sep 20, 2024

Mankind Pharma board approves up to Rs 10,000-crore fund raise via NCDs, CPs - Moneycontrol

Sep 20, 2024
pulisher
Sep 20, 2024

Mount Sinai Opens New Psychedelic Research Center in NYC - Mirage News

Sep 20, 2024
pulisher
Sep 19, 2024

Psychedelic research at a crossroads - Science

Sep 19, 2024
pulisher
Sep 19, 2024

Director GRYSKA DAVID W acquired 3,500 shares of Mind Medicine Inc [MNMD] - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

Bank of New York Mellon Corp Buys 203,216 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat

Sep 19, 2024
pulisher
Sep 18, 2024

Wall Street analysts’ outlook for Mind Medicine Inc (MNMD) - SETE News

Sep 18, 2024
pulisher
Sep 17, 2024

Examining the Potential Price Growth of Mind Medicine Inc (MNMD) - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Long Strange Trip Continues for Psychedelics in PTSD, TRD - Managed Healthcare Executive

Sep 17, 2024
pulisher
Sep 17, 2024

A closer look at Mind Medicine Inc (MNMD)’s stock price trends - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Given New $14.00 Price Target at Canaccord Genuity Group - Defense World

Sep 17, 2024
pulisher
Sep 16, 2024

Mannkind Corp (MNKD) gets rating Resumed from Leerink Partners - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) PT Lowered to $14.00 at Canaccord Genuity Group - MarketBeat

Sep 16, 2024
pulisher
Sep 10, 2024

MindMed Issues New Employee Share Options - TipRanks

Sep 10, 2024
pulisher
Sep 09, 2024

MindMed Announces New Employee Inducement Grants - Business Wire

Sep 09, 2024
pulisher
Sep 07, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of "Buy" by Analysts - MarketBeat

Sep 07, 2024
pulisher
Sep 05, 2024

MindMed Showcases Innovation at Investor Events - TipRanks

Sep 05, 2024
pulisher
Sep 04, 2024

MindMed to Participate in September Investor Conferences - StockTitan

Sep 04, 2024
pulisher
Sep 02, 2024

Mind Medicine (MindMed) Inc. Expected to Earn Q3 2024 Earnings of ($0.27) Per Share (NASDAQ:MNMD) - MarketBeat

Sep 02, 2024
pulisher
Aug 29, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target Raised to $55.00 - MarketBeat

Aug 29, 2024
pulisher
Aug 29, 2024

(MNMD) Long Term Investment Analysis - Stock Traders Daily

Aug 29, 2024
pulisher
Aug 27, 2024

Mind medicine director David Gryska buys $20,930 in company shares By Investing.com - Investing.com Canada

Aug 27, 2024
pulisher
Aug 26, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Director Acquires $20,930.00 in Stock - MarketBeat

Aug 26, 2024
pulisher
Aug 26, 2024

Mind medicine director David Gryska buys $20,930 in company shares - Investing.com India

Aug 26, 2024
pulisher
Aug 23, 2024

Mind Medicine Inc’s $75 Million Common Shares Offering - Global Legal Chronicle

Aug 23, 2024

Mind Medicine Inc Azioni (MNMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Mind Medicine Inc Azioni (MNMD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Liao Carrie
Chief Accounting Officer
Sep 25 '24
Sale
5.98
2,352
14,065
99,543
Barrow Robert
Chief Executive Officer
Sep 25 '24
Sale
5.98
19,771
118,231
545,772
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):